UCLA spinout developing the Polaris AI-assisted robotic platform for ophthalmic microsurgery, based in Malibu, California.
Horizon Surgical Systems is a surgical robotics company spun out of UCLA in 2021, headquartered in Malibu, California. The company develops the Polaris platform — described as the world's first AI-supported and robotics-enabled surgical system designed specifically for ophthalmology. Led by CEO Jean-Pierre Hubschman, M.D. and CTO Jacob Rosen, Ph.D., the technology was incubated over more than 15 years at UCLA before commercialization.
The Polaris platform features microsurgical robotics engineered for the precision requirements of ocular surgery, with AI-based guidance to extend — not replace — surgeons' capabilities. In October 2025, Horizon completed the world's first cataract surgery performed using the Polaris platform, performed by Uday Devgan, M.D. The platform remains an investigational device not yet FDA-approved for commercial sale.
Horizon raised a $30M Series A round, supported by the Los Angeles venture ecosystem.
Primary type & automation activities this supplier delivers:
AI-supported ophthalmic microsurgical robotic system for cataract surgery, designed to extend surgeon precision and reduce variability.
Contact Horizon Surgical Systems
WEBSITE
https://horizonsurgicalsystems.comHEADQUARTERS
United States
Company Facts
Founded
2021
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-